Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm

Prevention of nonmelanoma skin cancers remains a health priority due to high costs associated with this disease. Diclofenac and difluoromethylornithine (DFMO) have demonstrated chemopreventative efficacy for cutaneous squamous cell carcinomas. We designed a randomized study of the combination of DFM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Prev Res (Phila)
Autori principali: Jeter, Joanne M., Curiel-Lewandowski, Clara, Stratton, Steven P., Myrdal, Paul, Warneke, James, Einspahr, Janine G., Bartels, Hubert G., Yozwiak, Michael, Bermudez, Yira, Hu, Chengcheng, Bartels, Peter, Alberts, David S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778979/
https://ncbi.nlm.nih.gov/pubmed/26712942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-15-0232
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi